Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

350106

	registered interest
	date	11/06/2015
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Sheep Dipping
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the statement by George Eustice, Minister of State, Department for Environment, Food and Rural Affairs, on 10 June (HC Deb, col 136WH), who published the 1991 Health and Safety Executive report of an inquiry into sheep dipping; and to whom it was distributed.
	tabling member printed	The Countess of Mar
	uin	HL420
	answer	answer is ministerial correction date of answer 18/06/2015 answer text <p /> <p>The 1991 Health and Safety Executive (HSE) report presented the findings of a 1990 survey of sheep dipping and was published by HSE as an internal document in May 1991.</p><p> </p><p>The report was discussed at a meeting of the then Health and Safety Commission’s Agricultural Industry Advisory Committee (AIAC) working group, Chemicals In Agriculture (ChemAg), on 10 July 1991. The ChemAg working group membership included HSE, the Confederation of British Industry, the Trades Union Congress and other industry organisations.</p> answering member printed Baroness Altmann question first answered 18/06/2015 13:32:17 answering member 4533 label Biography information for Baroness Altmann
	tabling member	1861 label Biography information for The Countess of Mar

226479

	registered interest
	date	10/03/2015
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Aircraft: Air Conditioning
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under Secretary of State for Transport, Robert Goodwill, on 5 March (HC225928), what evidence is currently being reviewed by the Civil Aviation Authority in respect of the possibility of genetic factors which might influence individual susceptibility to environmental toxins.
	tabling member printed	The Countess of Mar
	uin	HL5601
	answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>The Civil Aviation Authority are reviewing the issue of genetic susceptibility to toxins in the context of documents provided by Dorset Coroner’s office.</p> answering member printed Baroness Kramer question first answered 17/03/2015 12:52:56 answering member 1557 label Biography information for Baroness Kramer
	tabling member	1861 label Biography information for The Countess of Mar

226833

	registered interest
	date	11/03/2015
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Aircraft: Air Conditioning
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under-Secretary of State for Transport, Robert Goodwill, on 4 March (HC225506), how many fume events occurred in flights observed by researchers conducting the Cranfield University study; whether the available health and safety standards and guidelines include the effects of pyrolised oil at temperatures exceeding 400 degrees Celsius in an enclosed space; and what assessment they have made of the advice from the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment that contaminated air is causing ill health but that they do not know the mechanism by which it has that effect.
	tabling member printed	The Countess of Mar
	uin	HL5627
	answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>A total of 38 flights had fumes or smells reported by at least one crew member or researcher during the Cranfield study. The Health and Safety Executive are responsible for introducing guidelines on health and safety at work legislation. However, the Cranfield study found that with respect to the conditions of flight that were experienced during the cabin air sampling, there was no evidence for pollutants occurring in cabin air at levels exceeding available health and safety standards and guidelines. The Committee on Toxicity (the COT) made a number of conclusions in their assessment. The Department welcomed these and forwarded the COT report to the European Aviation Safety Agency for their information.</p> answering member printed Baroness Kramer question first answered 17/03/2015 12:53:30 answering member 1557 label Biography information for Baroness Kramer
	tabling member	1861 label Biography information for The Countess of Mar

156576

	registered interest
	date	19/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government which organisations within the National Health Service or which represent members who provide services to the National Health Service are bound by the World Health Organisation’s International Classification of Diseases (ICD—10).
	tabling member printed	The Countess of Mar
	uin	HL2999
	answer	answer is ministerial correction date of answer 26/11/2014 answer text <p>The United Kingdom as a member state of the World Health Organization (WHO) is expected to comply with the WHO Nomenclature Regulations 1967 and is required to use the most current version of the International Classification of Diseases (ICD-10) for reporting cause of death and disease for compiling and publishing mortality and morbidity statistics. As such all providers of National Health Service funded care are required to submit ICD-10 codes for national reporting.</p><p> </p> answering member printed Earl Howe question first answered 26/11/2014 12:58:45 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar

156577

	registered interest
	date	19/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Fatigue Syndrome
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government why they do not record the numbers of people who are diagnosed with chronic fatigue syndrome/myalgic encephalomyelitis, given that current estimates are based on extrapolations from other countries.
	tabling member printed	The Countess of Mar
	uin	HL3000
	answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>With the exception of cancer, there is no comprehensive central record of disease diagnosis for any condition. In 2007, the National Institute for Health and Care Excellence produced the clinical guidance, <em>Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children</em> which estimates that the annual prevalence is approximately 4000 cases per million of the population.</p><p> </p> answering member printed Earl Howe question first answered 27/11/2014 12:42:01 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar

166877

	registered interest
	date	01/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Medical Records
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether clinical commissioning groups, general practitioner surgeries or any other National Health Service bodies have the legal right to provide insurance companies, or anyone else outside the National Health Service, with patients’ details, including their medical details; if so, which legislation permits such action; and, if any payment is received for supplying such information, to whom it is made.
	tabling member printed	The Countess of Mar
	uin	HL3295
	answer	answer is ministerial correction date of answer 05/12/2014 answer text <p>In the vast majority of cases National Health Service organisations may only provide confidential information about a patient to insurance companies and other third parties such as employers with the explicit consent of the patient. However, there may be a small number of cases where disclosure may take place without seeking consent, for example where there is a court order. Healthcare professionals who supply medical reports to insurance companies and employers may charge a fee for doing so; NHS organisations that supply copies of medical records may charge a fee that covers their costs.</p><p> </p> answering member printed Earl Howe question first answered 05/12/2014 14:32:42 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar

167280

	registered interest
	date	02/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government how many adverse reactions to Cervarix, Gardasil and unbranded human papilloma virus vaccines have been reported to the Medicines and Healthcare Products Regulatory Agency up to the most recent date; how many of those reports are of serious adverse reactions for each category; and what is the age specific rate that these figures represent.
	tabling member printed	The Countess of Mar
	uin	HL3381
	answer	answer is ministerial correction date of answer 16/12/2014 answer text <p>A total of 7947 suspected adverse reaction reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare Products Regulatory Agency (MHRA) via the Yellow Card Scheme up to 3 December 2014. It is important to note that a Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine may have been the cause. The frequency of known side effects is listed in the product information (the Summary of Product Characteristics for health professionals and the Patient Information Leaflet) which are provided with the vaccines.</p><p> </p><p> </p><p> </p><p>The following table provides a breakdown of these reports by brand and seriousness.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Vaccine Brand</p></td><td><p>Total number of reports</p></td><td><p>Number of serious reports (% of total)</p></td></tr><tr><td><p>Cervarix</p></td><td><p>6,260</p></td><td><p>1,762 (28%)</p></td></tr><tr><td><p>Gardasil</p></td><td><p>1,200</p></td><td><p>459 (38%)</p></td></tr><tr><td><p>HPV Brand unspecified</p></td><td><p>488</p></td><td><p>308 (63%)</p></td></tr><tr><td><p>Total</p></td><td><p>7,948*</p></td><td><p>2529 (32%)</p></td></tr></tbody></table><p> </p><p><em>Note:</em></p><p> </p><p>*The total number of reports received will not equal the total in the table above as some reports may have more than one suspect vaccine.</p><p> </p><p> </p><p> </p><p>The MHRA does not hold data on age-specific usage therefore we are unable to provide the age-specific rate that these figures represent. The MHRA continually reviews safety of the vaccine and, following administration of over 7 million doses in the UK alone, no serious new risks have been identified. The benefits in protecting against HPV-related disease far outweigh any possible side effects of the vaccine.</p><p> </p> answering member printed Earl Howe question first answered 16/12/2014 15:34:13 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar

228976

	registered interest
	date	23/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmacy
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what will be the position of patients, previously served by a dispensing doctor practice, who live within 1.6 km of a pharmacy that closes, but still retains its licence, as a result of the closure of the Essential Small Pharmacies Scheme on 1 April 2015.
	tabling member printed	The Countess of Mar
	uin	HL5941
	answer	answer is ministerial correction date of answer 25/03/2015 answer text <p>The ending of the essential small pharmacy local pharmaceutical services scheme on 31 March 2015 does not require such pharmacies to close. That is a decision for the individual contractor concerned. They may decide to return to the main National Health Service pharmaceutical list and come under the terms of the national community pharmacy contractual framework. Alternatively, they can decide to submit a proposal to NHS England to provide local pharmaceutical services. NHS England is working with individual providers of essential small pharmacies to ensure people in affected communities can continue to access appropriate NHS pharmaceutical services. However, if an essential small pharmacy – or any other type of pharmacy - did decide to close, it would no longer be able to provide NHS pharmaceutical services.</p><p> </p><p> </p><p> </p><p>Patients can at any time request in writing that a doctor provides them with NHS pharmaceutical services. Applications should be made via the doctor to the appropriate NHS England office. To be eligible to receive dispensing services from a doctor, a patient must meet certain criteria, such as having serious difficulty obtaining services from a pharmacy or the patient lives in a designated rural area, more than 1.6 kilometres from the nearest pharmacy. These criteria are set out in Regulation 48 of the National Health Services (Pharmaceutical Services and Local Pharmaceutical Services) Regulations 2013 – SI 2013/349. A patient must also be on the doctor’s patient list, or the patient list of the practice at which the doctor provides or performs primary medical services, and the practice must be authorised by NHS England to provide NHS dispensing services.</p><p> </p> answering member printed Earl Howe question first answered 25/03/2015 16:21:09 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar

61494

	registered interest
	date	11/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Antibiotics
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what has been the total antibiotic use for (1) human medicine in general practice, (2) human medicine in hospitals, and (3) veterinary medicine, for each year since 2004.
	tabling member printed	The Countess of Mar
	uin	HL272
	answer	answer is ministerial correction date of answer 19/06/2014 answer text <p>The following table provides information on the number of dispensed prescription items for human antibiotic medicines, in the community, for the period 2004 to 2013.</p><p> </p><table><tbody><tr><td colspan="2"><p>Number of prescription items for antibiotic medicines written in the United Kingdom and dispensed, in the community, in England <sup>1, 2</sup></p></td></tr><tr><td><p>Year</p></td><td><p>Items (000s)</p></td></tr><tr><td><p>2004</p></td><td><p>33,119.0</p></td></tr><tr><td><p>2005</p></td><td><p>33,825.7</p></td></tr><tr><td><p>2006</p></td><td><p>33,627.5</p></td></tr><tr><td><p>2007</p></td><td><p>35,429.1</p></td></tr><tr><td><p>2008</p></td><td><p>34,801.3</p></td></tr><tr><td><p>2009</p></td><td><p>34,182.9</p></td></tr><tr><td><p>2010</p></td><td><p>35,302.0</p></td></tr><tr><td><p>2011</p></td><td><p>35,333.7</p></td></tr><tr><td><p>2012</p></td><td><p>37,307.0</p></td></tr><tr><td><p>2013</p></td><td><p>35,429.1</p></td></tr></tbody></table><p><em>Sources</em>:</p><p>Prescription Cost Analysis (PCA) system. The Health &amp; Social Care Information Centre, Prescribing and Primary Care Services.</p><p><em> </em></p><p><em>Notes</em>:</p><p><sup>1. </sup>As classified within British National Formulary (BNF) paragraphs 5.1.1 <em>Penicillins</em>, 5.1.2 <em>Cephalosporins, carbapenems, and other beta-lactams</em>, 5.1.3 <em>Tetracyclines</em>, 5.1.4 <em>Aminoglycoside</em>s, 5.1.5 <em>Macrolides</em>, 5.1.6 <em>Clindamycin,</em>5.1.7 <em>Some other antibacterials</em>, 5.1.11 <em>Metronidazole and tinidazole, </em>5.1.12 <em>Quinolones</em>.</p><p><sup>2. </sup>Prescriptions include those written by general practitioners, nurses, pharmacists and other non-medical prescribers.</p><p> </p><p>In terms of human antibiotic medicines used in hospitals in England, it is not possible to provide reliable information. Within hospital data, information is reported as ‘packs', a measure which is not consistent over time or for aggregation, as one pack could refer to a single vial or to a box of 10 vials, or a bottle of capsules. Therefore to sum all the packs for a range of medicines is inappropriate and any resulting figures will be misleading.</p><p> </p><p>The following table provides information on the volume of antimicrobial sales from Market Authorisation Holders for veterinary medicine.</p><p> </p><table><tbody><tr><td colspan="2"><p>Sales of animal antibiotics within the United Kingdom <sup>1, 2, 3</sup></p></td></tr><tr><td><p>Year</p></td><td><p>Tonnes of active ingredient</p></td></tr><tr><td><p>2004</p></td><td><p>453</p></td></tr><tr><td><p>2005</p></td><td><p>446</p></td></tr><tr><td><p>2006</p></td><td><p>405</p></td></tr><tr><td><p>2007</p></td><td><p>387</p></td></tr><tr><td><p>2008</p></td><td><p>384</p></td></tr><tr><td><p>2009</p></td><td><p>402</p></td></tr><tr><td><p>2010</p></td><td><p>447</p></td></tr><tr><td><p>2011</p></td><td><p>346</p></td></tr><tr><td><p>2012</p></td><td><p>409</p></td></tr></tbody></table><p><em>Sources</em>:</p><p>The Veterinary Medicines Directorate, Department for Environment, Food and Rural Affairs</p><p><em> </em></p><p><em>Notes:</em></p><p><sup>1. </sup>It is not currently possible to separate the sales data by country and hence the data provided is for the UK.</p><p><sup>2. </sup>Sales data was provided voluntarily by veterinary pharmaceutical companies from 1998-2004. Data from 2005 onwards has been collected as a statutory requirement, as set out in the Veterinary Medicines Regulations.</p><p><sup>3. </sup>2013 data will be published later in the year.</p><p> </p> answering member printed Earl Howe question first answered 19/06/2014 11:52:16 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar

61942

	registered interest
	date	16/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patient Choice Schemes
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether patients have the legal right to be referred to any hospital provider of their choice, no matter where the consultant is located in England, subject to the provisos listed on the NHS website under Choosing your Hospital; whether patients diagnosed with chronic fatigue syndrome/myalgic encephalopathy in Sussex and elsewhere have been denied the opportunity to do so by local clinical commissioning groups when their general practitioners request a referral; and, if so, why.
	tabling member printed	The Countess of Mar
	uin	HL360
	answer	answer is ministerial correction date of answer 24/06/2014 answer text <p>The 2014-15 Choice Framework and the NHS Constitution, both available on .gov.uk, set out when patients have legal rights to choice.</p><p> </p><p>The NHS Constitution states that patients have the rightto make choices about the services commissioned by National Health Service bodies and to information to support these choices.</p><p> </p><p>The 2014-15 NHS Choice Framework establishes that if a patient needs to see a consultant or specialist as an outpatient for a physical or mental health condition, they can choose the organisation that provides their NHS care and treatment anywhere in England for their first outpatient appointment. They can also choose which consultant-led team or which mental health team led by a named health care professional will be in charge of their NHS care and treatment for their first outpatient appointment.</p><p> </p><p>The organisation can be any clinically appropriate health service provider with whom any clinical commissioning group or NHS England has a commissioning contract for the service required as a result of the referral, but the team must be clinically appropriate and led by a named consultant or health professional who is employed or engaged by that health service provider.</p><p> </p><p>There are also times that patients are not able to make a choice, and these are outlined in the <em>Choice Framework</em> and the <em>Handbook to the NHS Constitution</em>. For example, patients can only choose a hospital or clinic that offers the right treatment and care for their condition. Furthermore, if patients need urgent or emergency treatment, they cannot choose who they see.</p><p> </p><p>If a patient, who is not covered by the exemptions, has not been offered choice, or denied the opportunity to exercise choice by a clinical commissioning group, the 2014-15 Choice Framework sets out a clear complaints procedure.</p> answering member printed Earl Howe question first answered 24/06/2014 12:45:48 answering member 2000 label Biography information for Earl Howe
	tabling member	1861 label Biography information for The Countess of Mar